Inspire Investing LLC Has $665,000 Position in HealthEquity, Inc. (NASDAQ:HQY)

Inspire Investing LLC reduced its holdings in HealthEquity, Inc. (NASDAQ:HQY) by 71.1% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 6,932 shares of the company’s stock after selling 17,095 shares during the quarter. Inspire Investing LLC’s holdings in HealthEquity were worth $665,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors also recently made changes to their positions in HQY. Wasatch Advisors LP grew its position in shares of HealthEquity by 6.6% in the third quarter. Wasatch Advisors LP now owns 7,758,890 shares of the company’s stock valued at $635,065,000 after purchasing an additional 483,269 shares during the last quarter. Mackenzie Financial Corp lifted its stake in shares of HealthEquity by 16.0% in the second quarter. Mackenzie Financial Corp now owns 2,364,521 shares of the company’s stock valued at $203,822,000 after buying an additional 325,906 shares during the period. Vaughan Nelson Investment Management L.P. lifted its stake in shares of HealthEquity by 36.7% in the third quarter. Vaughan Nelson Investment Management L.P. now owns 843,423 shares of the company’s stock valued at $69,034,000 after buying an additional 226,563 shares during the period. Barclays PLC lifted its stake in shares of HealthEquity by 209.3% in the third quarter. Barclays PLC now owns 166,492 shares of the company’s stock valued at $13,628,000 after buying an additional 112,667 shares during the period. Finally, Thrivent Financial for Lutherans lifted its stake in shares of HealthEquity by 33.3% in the third quarter. Thrivent Financial for Lutherans now owns 293,624 shares of the company’s stock valued at $24,033,000 after buying an additional 73,404 shares during the period. 99.55% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research firms recently weighed in on HQY. Royal Bank of Canada increased their target price on shares of HealthEquity from $100.00 to $105.00 and gave the company an “outperform” rating in a research note on Tuesday, December 10th. The Goldman Sachs Group began coverage on shares of HealthEquity in a research note on Friday, November 15th. They issued a “neutral” rating and a $108.00 target price for the company. BTIG Research increased their target price on shares of HealthEquity from $110.00 to $130.00 and gave the company a “buy” rating in a research note on Thursday, November 14th. Barrington Research raised their price target on shares of HealthEquity from $105.00 to $120.00 and gave the stock an “outperform” rating in a research note on Monday, December 2nd. Finally, Bank of America raised their price target on shares of HealthEquity from $100.00 to $120.00 and gave the stock a “buy” rating in a research note on Wednesday, November 13th. One analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. According to MarketBeat.com, HealthEquity presently has a consensus rating of “Moderate Buy” and a consensus price target of $110.71.

Insider Buying and Selling

In related news, Director Stuart B. Parker sold 25,000 shares of the business’s stock in a transaction that occurred on Thursday, December 12th. The shares were sold at an average price of $96.72, for a total value of $2,418,000.00. Following the completion of the transaction, the director now owns 19,061 shares in the company, valued at $1,843,579.92. The trade was a 56.74 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Robert W. Selander sold 8,250 shares of the business’s stock in a transaction that occurred on Monday, December 9th. The stock was sold at an average price of $101.56, for a total transaction of $837,870.00. Following the completion of the transaction, the director now owns 66,469 shares of the company’s stock, valued at $6,750,591.64. This trade represents a 11.04 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 34,289 shares of company stock worth $3,355,718 in the last quarter. Insiders own 2.20% of the company’s stock.

HealthEquity Stock Performance

NASDAQ:HQY opened at $106.88 on Friday. HealthEquity, Inc. has a 1 year low of $65.01 and a 1 year high of $107.87. The firm has a 50 day moving average of $99.60 and a 200-day moving average of $87.35. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51. The stock has a market capitalization of $9.26 billion, a P/E ratio of 98.06, a price-to-earnings-growth ratio of 1.86 and a beta of 0.54.

HealthEquity (NASDAQ:HQY) last posted its earnings results on Monday, December 9th. The company reported $0.59 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.71 by ($0.12). HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. During the same quarter in the prior year, the firm posted $0.40 earnings per share. As a group, sell-side analysts anticipate that HealthEquity, Inc. will post 2.32 EPS for the current fiscal year.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.